physostigmine has been researched along with Methemoglobinemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukami, T; Higuchi, R; Kobayashi, Y; Nakajima, M; Yokoi, T | 1 |
1 other study(ies) available for physostigmine and Methemoglobinemia
| Article | Year |
|---|---|
Metabolic activation by human arylacetamide deacetylase, CYP2E1, and CYP1A2 causes phenacetin-induced methemoglobinemia.
Topics: Adult; Analgesics; Animals; Antipyretics; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Erythrocytes; Humans; Hydrolysis; In Vitro Techniques; Male; Methemoglobin; Methemoglobinemia; Mice; Mice, Inbred C57BL; Microsomes, Liver; Organophosphonates; Phenacetin; Phenetidine; Physostigmine; Young Adult | 2012 |